Preferred Name |
naxagolide |
|
Synonyms |
N-0500 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C042631 |
|
altLabel |
N-0500 (11C)-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho(1,2-b)(1,4)oxazin-9-ol (10bR)-4-((1-11C)Propyl)-3,4,4a,5,6,10b-hexahydro-2H-naphtho(1,2-b)(1,4)oxazin-9-ol dopazinol 3,4,4A,5,6,10B-hexahydro-4-propyl-2H-naphth(1,2-B)(1,4)oxozin-9-ol 2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, (4aR-trans)- 4-propyl-9-hydroxynaphthoxazine N 0500 (11C)-(+)-PHNO 4-propyl-9-hydroxy-1,2,3,4a,5,6-hexahydronaphthoxazine 11C-PHNO (11C)(+)-PHNO 2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-(propyl-1-11C)-, (10bR)- (+)-4-propyl-9-hydroxynaphthoxazine 1,2,3,4a,5,6-hexahydro-9-hydroxy-4-n-propyl-4H-naphth(1,2-b)(1,4)oxazine (11C)-(+)-propyl-hexahydro-naphtho-oxazin |
|
cui |
C0129565 C0048692 C2713353 |
|
HM |
D010078 |
|
II |
D002250 |
|
Inverse of RB |
22Z7E0X6OF 0 |
|
isa | ||
Mapped to | ||
MDA |
19841022 |
|
MeSH Frequency |
160 |
|
MMR |
20190715 |
|
notation |
C042631 |
|
PA |
D018491 |
|
prefLabel |
naxagolide |
|
RR |
88058-88-2 (naxagolide) |
|
SC |
1 |
|
Scope Statement |
structure given in first source |
|
SRC |
J Pharmacol Exp Ther 1984;230(3):569 |
|
TERMUI |
T000911368 T155783 T000954401 T000954402 T155787 T155786 T000954400 T753396 T000963318 T724500 T155784 T000954403 T155789 T000963400 T155790 T724501 |
|
TH |
NLM (2009) NLM (2008) FDA SRS (2013) NLM (2019) INN (19XX) NLM (2017) NLM (1984) |
|
tui |
T109 T121 |